IRVINE, Calif.–(BUSINESS WIRE)–Joe Kiani, Founder & CEO of Masimo & co-inventor of measure-through-motion pulse oximetry, was honored by SIBEN for improvements to neonatal health.
Author: Business Wire
Avellino Introduces New Multiplex Respiratory Panel
MENLO PARK, Calif.–(BUSINESS WIRE)– #avellinocov2test–Avellino has launched a multi-panel RT-PCR assay that quickly and accurately detects COVID-19 and other serious respiratory viruses in a single test.
Glaukos Corporation Announces Third Quarter 2020 Financial Results
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced finan…
Aerie Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Business Update
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucom…
Ocular Therapeutix™ Reports Third Quarter 2020 Financial Results and Business Update
BEDFORD, Mass.–(BUSINESS WIRE)—- $OCUL #OCUTX–Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today…
Alcon U.S. PRECISION1 Launch Momentum Bolstered by Strong Programs, Differentiated On-Eye Performance
FORT WORTH, Texas–(BUSINESS WIRE)–Alcon U.S. PRECISION1 Launch Momentum Bolstered by Strong Programs, Differentiated On-Eye Performance
Alcon U.S. PRECISION1 Launch Momentum Bolstered by Strong Programs, Differentiated On-Eye Performance
FORT WORTH, Texas–(BUSINESS WIRE)–Alcon U.S. PRECISION1 Launch Momentum Bolstered by Strong Programs, Differentiated On-Eye Performance
Kala Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Corporate Update
WATERTOWN, Mass.–(BUSINESS WIRE)–Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today reported financial results for t…
Aldeyra Therapeutics Announces Third-Quarter 2020 Financial Results and Provides Corporate Update
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a clinical-stage biotechnology company focused on the development of novel therapies with the potential to improve the lives of patients with immune-mediated diseas…
National Vision Holdings, Inc. Reports Third Quarter 2020 Financial Results
DULUTH, Ga.–(BUSINESS WIRE)–National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”) today reported its financial results for the third quarter ended September 26, 2020. “The National Vision team delivered an exceptionally st…
STAAR Surgical Begins Commercialization of EVO Viva™ Presbyopia Correcting Lens
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced the initial commercialization of its EVO Viva™…
STAAR Surgical Reports Third Quarter 2020 Results
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today reported financial results for the third quarter ended O…
Ophthalmic Femtosecond Lasers Market Will Accelerate at a CAGR of Over 6% Through 2020-2024 | Size, Share, Trends, Analysis and Forecast | Technavio
LONDON–(BUSINESS WIRE)– #GlobalOphthalmicFemtosecondLasersMarket–The Global Ophthalmic Femtosecond Lasers Market will grow by $ 170.80 mn during 2020-2024
Worldwide Tonometer Industry to 2025 – The Applanation Tonometry Segment is Dominating the Market – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Tonometer Market – Growth, Trends, and Forecasts (2020 – 2025)” report has been added to ResearchAndMarkets.com’s offering. The tonometer market is projected to register a CAGR of 5.2% over the forecast period. The major f…
Ocular Therapeutix Announces Receipt of a Permanent Category I CPT Code from the American Medical Association for the Insertion of Intracanalicular Inserts
BEDFORD, Mass.–(BUSINESS WIRE)—- $OCUL #OCUTX–Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today a…
Aldeyra to Participate in the American Academy of Ophthalmology Eyecelerator 2020 Virtual Conference on Friday, November 6
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced that President and CEO Todd C. Brady, M.D., Ph.D., will discuss Aldeyra’s novel therapeutic approaches to treating anterior and posterior segment ocu…
Global Lazy Eye (Amblyopia) Market Outlook 2019-2020 & 2027 by Type, Diagnosis, Treatment, End-user, Distribution, Geography, Competitive Landscape – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Lazy Eye – Global Market Outlook (2019-2027)” report has been added to ResearchAndMarkets.com’s offering. According to the report, the Global Lazy Eye Market is expected to grow at a CAGR of 9.8% during the forecast period…
The Ophthalmology PACS Market- Featuring Agfa-Gevaert NV, Carestream Health Inc., Carl Zeiss AG, among others to contribute to the Ophthalmology PACS Market Growth | Market Trends, Market Growth, Opportunities and Forecast 2024 | Technavio
LONDON–(BUSINESS WIRE)– #GlobalOphthalmologyPACSMarket–The Global Ophthalmology PACS Market will grow by USD 59.9 mn during 2020-2024
Noveome Biotherapeutics, Inc. to Present at the 10th Annual Traumatic Brain Injury Conference (Virtual), November 2-4, 2020
PITTSBURGH–(BUSINESS WIRE)–Noveome Biotherapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing next-generation biologics for the promotion and restoration of cellular integrity of inflamed or damaged tissues, announced tha…
GenSight Biologics annonce la validation de la demande d’autorisation de mise sur le marché (AMM) de LUMEVOQ® par l’Agence Européenne des Médicaments
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Paris:SIGHT) (Euronext : SIGHT, ISIN : FR0013183985, éligible PEA-PME), société biopharmaceutique dédiée au développement et à la commercialisation de thérapies géniques innovantes pour le tr…